Tao, Y.; Lang, C.C.; Petty, R.D.; Hall, P.S.; Baxter, M.A.
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)—A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial. Cancers 2025, 17, 601.
https://doi.org/10.3390/cancers17040601
AMA Style
Tao Y, Lang CC, Petty RD, Hall PS, Baxter MA.
N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)—A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial. Cancers. 2025; 17(4):601.
https://doi.org/10.3390/cancers17040601
Chicago/Turabian Style
Tao, Yuewei, Chim C. Lang, Russell D. Petty, Peter S. Hall, and Mark A. Baxter.
2025. "N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)—A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial" Cancers 17, no. 4: 601.
https://doi.org/10.3390/cancers17040601
APA Style
Tao, Y., Lang, C. C., Petty, R. D., Hall, P. S., & Baxter, M. A.
(2025). N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)—A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial. Cancers, 17(4), 601.
https://doi.org/10.3390/cancers17040601